Medical Note Template -- SOB Evaluation

Subjective:
Chief Complaint:
Follow-up for diabetes and hypertension management

Subjective::
- Richard presents for follow-up of diabetes and hypertension management.
- Reports feeling generally well and is making efforts to control blood glucose and blood pressure through improved diet and increased physical activity.
- Denies any medication side effects.
- Denies any known allergies.
- Reports adherence to prescribed metformin and ramipril without issues.
- Notes a recent family history change: his younger brother has been diagnosed with diabetes.

Objective:
Physical Examination:
- General appearance: Alert and oriented.
- Vital signs: Blood pressure 138/84 mmHg, weight 84 kg, body mass index 28.3.
- Cardiovascular: Heart sounds normal, no murmurs.
- Respiratory: Lungs clear to auscultation, no crepitations, wheezes, or rubs.
- Abdomen: Soft, no tenderness.
- Extremities: No ankle swelling.
- Neurological: Foot sensation intact.
- Skin: No foot ulcers or skin issues.
- Ambulation: Not specifically assessed.
- Throat, nasal mucosa, ear exam, rash: Not specifically assessed.

Assessment and Plan:
Reason for visit: Follow-up of diabetes and hypertension management.
- Type 2 diabetes mellitus: Glycemic control is stable with fasting glucose 7.8 mmol/L and hemoglobin A1c 7.2%. Continue metformin as prescribed. Reinforce dietary modifications focusing on high-fibre, low-glycemic foods, and avoidance of sugary drinks. Encourage regular physical activity, including walking and light strength training twice weekly. Refer to dietitian for further dietary guidance. Continue home blood glucose monitoring and maintain a log for review at next visit. Repeat laboratory investigations in 3 months.
- Hypertension: Blood pressure is improved but remains above target. Continue ramipril as prescribed. Advise limiting sodium intake to approximately 1 teaspoon per day, including processed and restaurant foods. Encourage use of herbs and spices for flavoring instead of salt. Reinforce importance of blood pressure control to reduce cardiovascular and renal risk.
- Dyslipidemia: Low-density lipoprotein cholesterol is 2.4 mmol/L and triglycerides are 1.8 mmol/L. Continue current management and dietary recommendations. Target low-density lipoprotein cholesterol under 2.0 mmol/L.
- Family history: Noted new diagnosis of diabetes in younger brother. Reinforce importance of ongoing risk factor management.
- No medication side effects or allergies reported.
- Follow-up: Reassess in 3 months with repeat laboratory investigations.